Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase IX (CA IX) is a transmembrane glycoprotein enzyme that catalyzes the reversible hydration of carbon dioxide. It is minimally expressed in normal tissues but highly upregulated in various solid tumors, particularly under hypoxic conditions. CA IX plays a crucial role in pH regulation and cell adhesion within the tumor microenvironment, promoting tumor growth and metastasis. It serves as a prognostic marker and a therapeutic target for cancer.
Inhibition of carbonic anhydrase activity, disruption of pH regulation in tumor microenvironment
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase IX (CA IX).